不良研究所

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, is among the experts quoted by The Globe and Mail.

"Affordability and access are some of the ethical issues raised by the spectre of regenerative medicine, says Jonathan Kimmelman, a James 不良研究所 professor in the biomedical ethics unit at 不良研究所. 鈥淩ight now we鈥檙e seeing some kind of mind-blowing advances in the field of gene therapy in terms of the clinical applications, but these are incredibly expensive technologies and health care systems will only be able to afford them by taking resources out of other aspects of the health care system,鈥� Dr. Kimmelman says."